JCOG

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/06/20 01:16:22」(JST)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas.

Yoshino A, Tashiro S, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Sano E, Tsumoto K.SourceDepartment of Neurological Surgery, Nihon University School of Medicine, 30-1 Oyaguchi-Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan. ayoshino@med.nihon-u.ac.jp
International journal of oncology.Int J Oncol.2011 Sep;39(3):529-42. doi: 10.3892/ijo.2011.1068. Epub 2011 Jun 6.
Temozolomide (TMZ) is an alkylating agent that has yielded significant benefits and is a current standard agent in the treatment of malignant gliomas. However, its survival benefit remains unsatisfactory. Recently, a synergistic antitumor effect between TMZ and interferon-β (IFN-β) was reported in
PMID 21805051

Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphoma.

Ishitsuka K, Tsukasaki K, Tamura K.SourceDivision of Oncology, Hematology and Infectious Disease, Department of Internal Medicine, Fukuoka University, Fukuoka, Japan; Lymphoma Study Group of the Japan Clinical Oncology Group (JCOG). kenjiishitsuka@fukuoka-u.ac.jp.
Drugs of today (Barcelona, Spain : 1998).Drugs Today (Barc).2011 Aug;47(8):615-23.
Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell malignancy caused by human T-cell lymphotropic virus type I, and its clinical subtypes are categorized into smoldering, chronic, lymphoma and acute types. The standard care for patients with the acute, lymphoma and unfavorable chronic types
PMID 21850284